DK0412940T3 - Hydantoin eller imidazolidintrionderivater til forebyggelse eller behandling af nyresvigt. - Google Patents

Hydantoin eller imidazolidintrionderivater til forebyggelse eller behandling af nyresvigt.

Info

Publication number
DK0412940T3
DK0412940T3 DK90810592.7T DK90810592T DK0412940T3 DK 0412940 T3 DK0412940 T3 DK 0412940T3 DK 90810592 T DK90810592 T DK 90810592T DK 0412940 T3 DK0412940 T3 DK 0412940T3
Authority
DK
Denmark
Prior art keywords
renal failure
hydantoin
imidazolidinedrione
prevention
derivatives
Prior art date
Application number
DK90810592.7T
Other languages
Danish (da)
English (en)
Inventor
Hiroki Mikami
Kazuharu Ienaga
Original Assignee
Nippon Zoki Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zoki Pharmaceutical Co filed Critical Nippon Zoki Pharmaceutical Co
Application granted granted Critical
Publication of DK0412940T3 publication Critical patent/DK0412940T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK90810592.7T 1989-08-09 1990-08-07 Hydantoin eller imidazolidintrionderivater til forebyggelse eller behandling af nyresvigt. DK0412940T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1207699A JP2678499B2 (ja) 1989-08-09 1989-08-09 尿毒症毒素低下剤

Publications (1)

Publication Number Publication Date
DK0412940T3 true DK0412940T3 (da) 1997-07-14

Family

ID=16544105

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90810592.7T DK0412940T3 (da) 1989-08-09 1990-08-07 Hydantoin eller imidazolidintrionderivater til forebyggelse eller behandling af nyresvigt.

Country Status (8)

Country Link
US (1) US5084473A (fr)
EP (1) EP0412940B1 (fr)
JP (1) JP2678499B2 (fr)
KR (1) KR0151389B1 (fr)
AT (1) ATE147625T1 (fr)
DE (1) DE69029693T2 (fr)
DK (1) DK0412940T3 (fr)
ES (1) ES2095870T3 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2678499B2 (ja) * 1989-08-09 1997-11-17 日本臓器製薬 株式会社 尿毒症毒素低下剤
US5912261A (en) * 1994-12-20 1999-06-15 Nippon Zoki Pharmaceutical Co., Ltd. Carboxyalkyl heterocyclic derivatives
US6197806B1 (en) * 1995-12-20 2001-03-06 Nippon Zoki Pharmaceutical Co., Ltd. Eliminating agent for activated oxygen and free radicals
JPH10182460A (ja) * 1996-12-27 1998-07-07 Nippon Zoki Pharmaceut Co Ltd ３−デオキシグルコソン生成阻害剤
AU754989B2 (en) * 1998-11-16 2002-11-28 Nippon Zoki Pharmaceutical Co., Ltd. A therapeutic agent for intractable vasculitis
JP4711523B2 (ja) * 2001-02-13 2011-06-29 日本臓器製薬株式会社 低アルブミン血症改善剤
TWI353979B (en) 2002-04-10 2011-12-11 Nippon Zoki Pharmaceutical Co Novel crystal form of 5-hydroxy-1-methylhydantoin
JP2004123735A (ja) * 2002-09-11 2004-04-22 Nippon Zoki Pharmaceut Co Ltd 光学活性（ｓ）−ヒダントイン誘導体
JP2004123736A (ja) * 2002-09-11 2004-04-22 Nippon Zoki Pharmaceut Co Ltd 光学活性（ｒ）−ヒダントイン誘導体
US20060241163A1 (en) * 2005-04-20 2006-10-26 Kaoru Okamoto Optically active (S)-hydantoin derivative
US20060241162A1 (en) * 2005-04-20 2006-10-26 Kaoru Okamoto Optically active (R)-hydantoin derivative
EP1961888A1 (fr) * 2005-12-13 2008-08-27 Osamu Ito Dispositif de stores combines et rouleau d enroulement pour feuilles de canevas
JP4660616B2 (ja) * 2009-08-31 2011-03-30 株式会社東芝 基板検査装置
KR102311915B1 (ko) 2014-02-26 2021-10-13 니폰 조키 세야쿠 가부시키가이샤 만성 신장병의 진행 억제 또는 개선제
EP3639821B1 (fr) 2017-06-13 2024-08-28 National Cancer Center Inhibiteur de la carcinogenèse

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
JPH062748B2 (ja) * 1984-03-08 1994-01-12 日本臓器製薬株式会社 新規ヒダントイン誘導体及び該化合物を有効成分として含有する医薬組成物
AU578068B2 (en) * 1984-03-08 1988-10-13 Nippon Zoki Pharmaceutical Co., Ltd. Hydantoin derivatives and pharmaceutical compositions containing them
JPH0686436B2 (ja) * 1984-11-15 1994-11-02 日本臓器製薬株式会社 新規ヒダントイン誘導体及び該化合物を含有する医薬組成物
JPH0764729B2 (ja) * 1985-02-06 1995-07-12 日本臓器製薬株式会社 イミダゾリジントリオン誘導体を含有する医薬組成物
EP0194226B1 (fr) * 1985-02-06 1990-02-07 Nippon Zoki Pharmaceutical Co. Ltd. Composition pharmaceutique contenant un dérivé d'imidazolidinetrione ou un de ses sels pharmaceutiquement acceptable
US4853401A (en) * 1987-04-01 1989-08-01 G. D. Searle & Co. Spiro-hydantoins as aldose reductase inhibitors
JP2678499B2 (ja) * 1989-08-09 1997-11-17 日本臓器製薬 株式会社 尿毒症毒素低下剤

Also Published As

Publication number Publication date
DE69029693D1 (de) 1997-02-27
KR0151389B1 (ko) 1998-10-15
EP0412940A3 (en) 1991-10-23
ES2095870T3 (es) 1997-03-01
DE69029693T2 (de) 1997-05-07
JPH0372463A (ja) 1991-03-27
EP0412940B1 (fr) 1997-01-15
US5084473A (en) 1992-01-28
KR910004191A (ko) 1991-03-28
JP2678499B2 (ja) 1997-11-17
ATE147625T1 (de) 1997-02-15
EP0412940A2 (fr) 1991-02-13

Similar Documents

Publication Publication Date Title
DK0412940T3 (da) Hydantoin eller imidazolidintrionderivater til forebyggelse eller behandling af nyresvigt.
DK1029853T3 (da) Heteroaromatiske bicykliske derivativer, der er egnede som anticancermidler
DE69528005D1 (de) Prolineamid-Derivate
ES8603870A1 (es) Un procedimiento para la preparacion de derivados de 2,2'-iminobisetanol.
DK0622361T3 (da) Heterocykliske forbindelser som bradykininantagonister
PT979244E (pt) Derivados de ciclosporina, sua preparacao e composicoes farmaceuticas que os contem
DE69716810D1 (de) 2,3-Disubstituierte-(5,6)-heteroarylkondensierte-pyrimidin-4-one
DE69635996D1 (de) Pharmazeutische zusammensetzungen mit hydroximsäurederivaten
DE68906609D1 (de) Dopamin-vorlaeufer.
PT97395A (pt) Processo para a preparacao de 2,9-di-substituidas-4h-pirido{1,2-a}-pirimidin-4-onas e de composicoes farmaceuticas que os contem
WO1992019211A3 (fr) Imidazobenzoquinones et composition contenant ces dernieres permettant de prevenir ou de traiter l'hypertension ou l'insuffisance cardiaque
DK0536269T3 (da) Anvendelse af inositol-triphosphat til fremstilling af medikamenter
EP1666041A3 (fr) Derivés de la xanthine contre désordres neurodégénératifs
NO157643C (no) Anvendelse av sitronsyre for aa forhindre nedbrytning av farmasoeytisk taalbare syreaddisjonssalter av tienopyridinderivater.
DK122191D0 (da) Benzimidazolderivat og fysiologisk acceptable salte heraf samt fremgangsmaade til fremstilling af samme
DK0561882T3 (da) Hydroxamsyrederivater, som inhiberer lipoxygenase
DE69828390D1 (de) Diaminotrifluoromethylpyrimidinderivate enthaltende antikrebs-zusammensetzung
PT855398E (pt) Derivados sasquiterpeno tendo actividade antiviral
DK360388D0 (da) Laegemiddel til behandling af hjerteinsufficiens
DK434789D0 (da) 3-piperidinyl-indazolderivater, fremgangsmaade til fremstilling deraf samt praeparater indeholdende samme
FR2642648B1 (fr) Utilisation de derives d'alkyl-5 pyridazine comme medicaments actifs sur le systeme cholinergique
ATE54665T1 (de) Hydantoin-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ES544133A0 (es) Un procedimiento para la preparacion de derivados de imidazol.
DK165967C (da) Anvendelse af en 2-oxo-imidazolidinforbindelse til fremstilling af et farmaceutisk praeparat
RU93058386A (ru) Противовирусная комбинация, содержащая неуклеозидный аналог, фармацевтическая композиция, способ лечения